Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 3, 2015, Pages 502-514

  Schewel, Dimitry ^a   Frerker, Christian ^a   Schewel, Jury ^a   Wohlmuth, Peter ^b   Meincke, Felix ^a   Thielsen, Thomas ^a   Kreidel, Felix ^a   Kuck, Karl Heinz ^a   Schäfer, Ulrich ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b Asklepios Proresearch   (Germany)

Author keywords

Aortic valvular stenosis; Paravalvular leak; Transcatheter aortic valve implantation

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CLOPIDOGREL; HEPARIN; LACTATE DEHYDROGENASE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; BALLOON CATHETER; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARAVALVULAR LEAK; PROSTHESIS FAILURE; SELF EXPANDING STENT; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VASCULAR DISEASE; VERY ELDERLY; ADVERSE EFFECTS; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BLOOD; DEVICES; GERMANY; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BIOMARKERS; CARDIAC CATHETERIZATION; FEMALE; GERMANY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS FAILURE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84923083241     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25295     Document Type: Article

References (29)

1. Astor BC, Kaczmarek RG, Hefflin B, Daley WR. Mortality after aortic valve replacement: Results from a nationally representative database. Ann Thorac Surg 2000;70:1939-1945.
2. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002;106:3006-3008.
3. Cribier A, Eltchaninoff H, Tron C, Bauer F, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: Midterm follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006;47:1214-1223.
4. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in highrisk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006;114:1616-1624.
5. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: Multicenter experience. Circulation 2007;116:I240-I245.
6. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
7. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-763.
8. De Jaegere PP, Piazza N, Galema TW, et al. Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve revalving system aortic valve bioprosthesis. EuroIntervention 2008;4:351-357.
9. Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: Incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 2011;97:899-906.
10. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.
11. Sinning J-M, Hammerstingl C, Vasa-Nicotera M, et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. JACC 2012;59:1134-1141.
12. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686-1695.
13. Gorlin R, McMillan IK, Medd WE, et al. Dynamics of the circulation in aortic valvular disease. Am J Med 1955;18:855-870.
14. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: A consensus report from the valve academic research consortium. Eur Heart J 2011;32:205-217.
15. Edmunds LHJ, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996;62:932-935.
16. Wood DA, Tops LF, Mayo JR, et al. Role of multislice computed tomography in transcatheter aortic valve replacement. Am J Cardiol 2009;103:1295-1301.
17. Rallidis LS, Moyssakis IE, Ikonomidis I, Nihoyannopoulos P. Natural history of early aortic paraprosthetic regurgitation: A five-year follow-up. Am Heart J 1999;138:351-357.
18. Tops LF, Wood DA, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2008;1:321-330.
19. Otani K, Takeuchi M, Kaku K, et al. Assessment of the aortic root using real-time 3D transesophageal echocardiography. Circ J 2010;74:2649-2657.
20. Schultz CJ, Moelker A, Piazza N, et al. Three dimensional evaluation of the aortic annulus using multislice computer tomography: Are manufacturer's guidelines for sizing for percutaneous aortic valve replacement helpful? Eur Heart J 2010;31:849-856.
21. Koos R, Mahnken AH, Dohmen G, et al. Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol 2011;150:142-145.
22. Zegdi R, Ciobotaru V, Noghin M, Fabiani JN. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol 2008;51:579-584.
23. Schultz CJ, Weustink A, Piazza N, et al. Geometry and degree of apposition of the CoreValve ReValving system with multi-slice computed tomography after implantation in patients with aortic stenosis. J Am Coll Cardiol 2009;54:911-918.
24. John D, Buellesfeld L, Yuecel S, et al. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv 2010;3:233-243.
25. Sherif MA, Abdel-Wahab M, Stocker B, Geist V, Richardt D, Tolg R, Richardt G. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol 2010;56:1623-1629.
26. Brown ML, Schaff HV, Sarano ME, et al. Is the European system for cardiac operative risk evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg 2008;136:566-571.
27. Zhang Z, Ni H, Lu B, Xu X. Changes in brain natriuretic peptide are correlated with changes in global end-diastolic volume index. J Thorac Dis 2013;5:156-160.
28. Ray SG. Natriuretic peptides in heart valve disease. Heart 2006;92:1194-1197.
29. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: Effect of stretching. Endocrinology 1993;132:1961-1970.